{"id":406512,"date":"2020-12-30T08:08:33","date_gmt":"2020-12-30T13:08:33","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=406512"},"modified":"2020-12-30T08:08:33","modified_gmt":"2020-12-30T13:08:33","slug":"biocept-enters-into-laboratory-services-agreements-with-two-southern-california-regional-independent-physician-associations","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/biocept-enters-into-laboratory-services-agreements-with-two-southern-california-regional-independent-physician-associations\/","title":{"rendered":"Biocept Enters into Laboratory Services Agreements with Two Southern California Regional Independent Physician Associations"},"content":{"rendered":"
\n

Expands physician and patient access to Biocept’s Target Selector\u2122 liquid biopsy testing for the management of patients diagnosed with cancer<\/h2>\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n SAN DIEGO<\/span>, Dec. 30, 2020<\/span> \/PRNewswire\/ — Biocept, Inc.<\/a><\/u>\u00a0(Nasdaq: BIOC),\u00a0a leading commercial provider of molecular diagnostic assays, products and services designed to provide physicians with clinically actionable information to improve patient outcomes,\u00a0announces that it has entered into laboratory services agreements with independent physician associations (IPAs) providing physicians and patients in-network access to Biocept’s full array of Target Selector\u2122 liquid biopsy oncology assays and services. Both IPAs are headquartered in San Diego<\/span> and combined serve more than 70,000 covered lives in the Southern California<\/span> region.\u00a0 <\/p>\n

\n

\n
\n \"Biocept
\n <\/a>\n <\/p>\n<\/p><\/div>\n

“We see a role for our Target Selector\u2122 assays and services in value based delivery health plans such as IPAs with goals to deliver cost-efficient and high-quality care,” said Michael Nall<\/span>, Biocept’s President and CEO. “Our Target Selector\u2122 provides evidence-based, clinically actionable results that allow physicians the ability to choose individual biomarker tests or larger liquid biopsy panels to provide the best approach for each patient.\u00a0Contracting with value-based providers is a priority for Biocept and we expect to enter into additional services agreements in the future.”<\/p>\n

\n About Biocept
<\/b>Biocept, Inc.\u202fis a molecular diagnostics company with commercialized assays for lung, breast, gastric, colorectal and prostate cancers, and melanoma. The Company uses its proprietary liquid biopsy technology to provide physicians with clinically actionable information for treating and monitoring patients diagnosed with cancer. The Company’s patented Target Selector\u2122 liquid biopsy technology platform captures and analyzes tumor-associated molecular markers in both circulating tumor cells (CTCs) and in circulating tumor DNA (ctDNA).\u00a0With thousands of tests performed, the platform has demonstrated the ability to identify cancer mutations and alterations to inform physicians about a patient’s disease and therapeutic options.\u00a0Additionally, Biocept is offering nationwide COVID-19 polymerase chain reaction (PCR) testing to support public health efforts during this unprecedented pandemic.\u00a0For additional information, please visit www.biocept.com<\/a>.<\/p>\n

\n Forward-Looking Statements Disclaimer Statement<\/b>\n <\/p>\n

This release contains forward-looking statements that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although we believe that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, we can give no assurance that such expectations and assumptions will prove to have been correct. Forward-looking statements are generally identifiable by the use of words like “may,” “will,” “should,” “could,” “expect,” “anticipate,” “estimate,” “believe,” “intend,” or “project” or the negative of these words or other variations on these words or comparable terminology. To the extent that statements in this release are not strictly historical, including without limitation statements regarding our expectation of entering into additional services agreements in the future and the ability of our assays to improve the outcomes of patients diagnosed with cancer, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous risks and uncertainties, including the risk that our products and services may not perform as expected and the risk that we will not be able to enter into additional services agreements. These and other risks are described in greater detail under the “Risk Factors” heading of our Quarterly Report on Form 10-Q for the quarter ended\u00a0September 30, 2020. The effects of such risks and uncertainties could cause actual results to differ materially from the forward-looking statements contained in this release. We do not plan to update any such forward-looking statements and expressly disclaim any duty to update the information contained in this press release except as required by law. Readers are advised to review our filings with the\u00a0SEC, which can be accessed over the Internet at the\u00a0SEC’s\u00a0website located at\u00a0www.sec.gov<\/a>.<\/p>\n

\n
\n Contact:
<\/u>
\n <\/b>
\n LHA Investor Relations
<\/b>
\n Jody Cain<\/span>
\n
\n Jcain@lhai.com<\/a>
\n
310-691-7100<\/p>\n

<\/div>\n

\n \"Cision\" View original content to download multimedia:http:\/\/www.prnewswire.com\/news-releases\/biocept-enters-into-laboratory-services-agreements-with-two-southern-california-regional-independent-physician-associations-301199215.html<\/a><\/p>\n

SOURCE Biocept, Inc.<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Expands physician and patient access to Biocept’s Target Selector\u2122 liquid biopsy testing for the management of patients diagnosed with cancer PR Newswire SAN DIEGO, Dec. 30, 2020 \/PRNewswire\/ — Biocept, Inc.\u00a0(Nasdaq: BIOC),\u00a0a leading commercial provider of molecular diagnostic assays, products and services designed to provide physicians with clinically actionable information to improve patient outcomes,\u00a0announces that it has entered into laboratory services agreements with independent physician associations (IPAs) providing physicians and patients in-network access to Biocept’s full array of Target Selector\u2122 liquid biopsy oncology assays and services. Both IPAs are headquartered in San Diego and combined serve more than 70,000 covered lives in the Southern California region.\u00a0 “We see a role for our Target Selector\u2122 assays and services in value based … <\/p>\n

Continue reading “Biocept Enters into Laboratory Services Agreements with Two Southern California Regional Independent Physician Associations”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-406512","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nBiocept Enters into Laboratory Services Agreements with Two Southern California Regional Independent Physician Associations - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/biocept-enters-into-laboratory-services-agreements-with-two-southern-california-regional-independent-physician-associations\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Biocept Enters into Laboratory Services Agreements with Two Southern California Regional Independent Physician Associations - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Expands physician and patient access to Biocept’s Target Selector\u2122 liquid biopsy testing for the management of patients diagnosed with cancer PR Newswire SAN DIEGO, Dec. 30, 2020 \/PRNewswire\/ — Biocept, Inc.\u00a0(Nasdaq: BIOC),\u00a0a leading commercial provider of molecular diagnostic assays, products and services designed to provide physicians with clinically actionable information to improve patient outcomes,\u00a0announces that it has entered into laboratory services agreements with independent physician associations (IPAs) providing physicians and patients in-network access to Biocept’s full array of Target Selector\u2122 liquid biopsy oncology assays and services. Both IPAs are headquartered in San Diego and combined serve more than 70,000 covered lives in the Southern California region.\u00a0 “We see a role for our Target Selector\u2122 assays and services in value based … Continue reading "Biocept Enters into Laboratory Services Agreements with Two Southern California Regional Independent Physician Associations"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/biocept-enters-into-laboratory-services-agreements-with-two-southern-california-regional-independent-physician-associations\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-30T13:08:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/276540\/biocept_inc_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biocept-enters-into-laboratory-services-agreements-with-two-southern-california-regional-independent-physician-associations\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biocept-enters-into-laboratory-services-agreements-with-two-southern-california-regional-independent-physician-associations\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Biocept Enters into Laboratory Services Agreements with Two Southern California Regional Independent Physician Associations\",\"datePublished\":\"2020-12-30T13:08:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biocept-enters-into-laboratory-services-agreements-with-two-southern-california-regional-independent-physician-associations\\\/\"},\"wordCount\":680,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biocept-enters-into-laboratory-services-agreements-with-two-southern-california-regional-independent-physician-associations\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/276540\\\/biocept_inc_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biocept-enters-into-laboratory-services-agreements-with-two-southern-california-regional-independent-physician-associations\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biocept-enters-into-laboratory-services-agreements-with-two-southern-california-regional-independent-physician-associations\\\/\",\"name\":\"Biocept Enters into Laboratory Services Agreements with Two Southern California Regional Independent Physician Associations - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biocept-enters-into-laboratory-services-agreements-with-two-southern-california-regional-independent-physician-associations\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biocept-enters-into-laboratory-services-agreements-with-two-southern-california-regional-independent-physician-associations\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/276540\\\/biocept_inc_Logo.jpg\",\"datePublished\":\"2020-12-30T13:08:33+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biocept-enters-into-laboratory-services-agreements-with-two-southern-california-regional-independent-physician-associations\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biocept-enters-into-laboratory-services-agreements-with-two-southern-california-regional-independent-physician-associations\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biocept-enters-into-laboratory-services-agreements-with-two-southern-california-regional-independent-physician-associations\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/276540\\\/biocept_inc_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/276540\\\/biocept_inc_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biocept-enters-into-laboratory-services-agreements-with-two-southern-california-regional-independent-physician-associations\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Biocept Enters into Laboratory Services Agreements with Two Southern California Regional Independent Physician Associations\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Biocept Enters into Laboratory Services Agreements with Two Southern California Regional Independent Physician Associations - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/biocept-enters-into-laboratory-services-agreements-with-two-southern-california-regional-independent-physician-associations\/","og_locale":"en_US","og_type":"article","og_title":"Biocept Enters into Laboratory Services Agreements with Two Southern California Regional Independent Physician Associations - Market Newsdesk","og_description":"Expands physician and patient access to Biocept’s Target Selector\u2122 liquid biopsy testing for the management of patients diagnosed with cancer PR Newswire SAN DIEGO, Dec. 30, 2020 \/PRNewswire\/ — Biocept, Inc.\u00a0(Nasdaq: BIOC),\u00a0a leading commercial provider of molecular diagnostic assays, products and services designed to provide physicians with clinically actionable information to improve patient outcomes,\u00a0announces that it has entered into laboratory services agreements with independent physician associations (IPAs) providing physicians and patients in-network access to Biocept’s full array of Target Selector\u2122 liquid biopsy oncology assays and services. Both IPAs are headquartered in San Diego and combined serve more than 70,000 covered lives in the Southern California region.\u00a0 “We see a role for our Target Selector\u2122 assays and services in value based … Continue reading \"Biocept Enters into Laboratory Services Agreements with Two Southern California Regional Independent Physician Associations\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/biocept-enters-into-laboratory-services-agreements-with-two-southern-california-regional-independent-physician-associations\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-30T13:08:33+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/276540\/biocept_inc_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biocept-enters-into-laboratory-services-agreements-with-two-southern-california-regional-independent-physician-associations\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biocept-enters-into-laboratory-services-agreements-with-two-southern-california-regional-independent-physician-associations\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Biocept Enters into Laboratory Services Agreements with Two Southern California Regional Independent Physician Associations","datePublished":"2020-12-30T13:08:33+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biocept-enters-into-laboratory-services-agreements-with-two-southern-california-regional-independent-physician-associations\/"},"wordCount":680,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biocept-enters-into-laboratory-services-agreements-with-two-southern-california-regional-independent-physician-associations\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/276540\/biocept_inc_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biocept-enters-into-laboratory-services-agreements-with-two-southern-california-regional-independent-physician-associations\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/biocept-enters-into-laboratory-services-agreements-with-two-southern-california-regional-independent-physician-associations\/","name":"Biocept Enters into Laboratory Services Agreements with Two Southern California Regional Independent Physician Associations - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biocept-enters-into-laboratory-services-agreements-with-two-southern-california-regional-independent-physician-associations\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biocept-enters-into-laboratory-services-agreements-with-two-southern-california-regional-independent-physician-associations\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/276540\/biocept_inc_Logo.jpg","datePublished":"2020-12-30T13:08:33+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biocept-enters-into-laboratory-services-agreements-with-two-southern-california-regional-independent-physician-associations\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/biocept-enters-into-laboratory-services-agreements-with-two-southern-california-regional-independent-physician-associations\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biocept-enters-into-laboratory-services-agreements-with-two-southern-california-regional-independent-physician-associations\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/276540\/biocept_inc_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/276540\/biocept_inc_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biocept-enters-into-laboratory-services-agreements-with-two-southern-california-regional-independent-physician-associations\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Biocept Enters into Laboratory Services Agreements with Two Southern California Regional Independent Physician Associations"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/406512","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=406512"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/406512\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=406512"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=406512"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=406512"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}